Cantel Medical (Cantel Medical) Interest Expense : $-62 Mil (TTM As of Apr. 2021)

View and export this data going back to 1992. Start your Free Trial

What is Cantel Medical Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Cantel Medical's interest expense for the three months ended in Apr. 2021 was $ -15 Mil. Its interest expense for the trailing twelve months (TTM) ended in Apr. 2021 was $-62 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Cantel Medical's Operating Income for the three months ended in Apr. 2021 was $ 46 Mil. Cantel Medical's Interest Expense for the three months ended in Apr. 2021 was $ -15 Mil. Cantel Medical's Interest Coverage for the quarter that ended in Apr. 2021 was 3.07. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cantel Medical Interest Expense Historical Data

The historical data trend for Cantel Medical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantel Medical Interest Expense Chart

Cantel Medical Annual Data

Trend

Jul11

Jul12

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Interest Expense

Get a 7-Day Free Trial

-3.32

-4.30

-5.29

-9.51

-41.36

Cantel Medical Quarterly Data
	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21
Interest Expense	Get a 7-Day Free Trial															-10.11	-15.27	-16.29	-15.49	-14.85

Cantel Medical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Apr. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-62 Mil.

Cantel Medical (NYSE:CMD) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Cantel Medical's Interest Expense for the three months ended in Apr. 2021 was $-15 Mil. Its Operating Income for the three months ended in Apr. 2021 was $46 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Apr. 2021 was $903 Mil.

Cantel Medical's Interest Coverage for the quarter that ended in Apr. 2021 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Apr. 2021 )	/	Interest Expense (Q: Apr. 2021 )
	=	-1	*	45.524	/	-14.845
	=	3.07

The higher the ratio, the stronger the company's financial strength is.

Cantel Medical (Cantel Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cantel Medical Corp (NYSE:CMD) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 Clove Road, 9th Floor, Little Falls, NJ, USA, 07424

Website

http://www.cantelmedical.com

Cantel Medical is a New Jersey-based manufacturer of hospital supplies for infection prevention, which include products used in endoscope disinfection, water purification systems for use in dialysis treatment, and dental supplies. The firm reports in four segments: medical (46% of fiscal 2020 sales), dental (32%), life sciences (19%), and dialysis (3%). Geographic exposure is primarily in the U.S., which accounts for about 75% of revenue, with international markets making up the remaining 25%.

Executives

Ann E Berman	director	255 STATE STREET, BOSTON MA 02109
Jeffrey Z Mann	officer: SVP, General Counsel	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
George L Fotiades	director, officer: Chief Executive Officer	281 SUMMIT AVENUE, SUMMIT NJ 07901
Charles M Diker	director, 10 percent owner, officer: Chairman	ONE NEW YORK PLAZA, NEW YORK NY 10004
Shaun M. Blakeman	officer: SVP - CFO	C/O CANTEL MEDICAL CORP., 150 CLOVE ROAD, LITTLE FALLS NJ 07424
Jean Casner	officer: SVP and CHRO	150 CLOVE ROAD, LITTLE FALLS NJ 07424
Brian Capone	officer: SVP and Princ. Accounting Ofr	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Peter G Clifford	officer: President and COO	40 TOURNAMENT DRIVE SOUTH, HAWTHORN WOODS IL 60047
Seth M Yellin	officer: Executive Vice President	150 CLOVE ROAD 9TH FLOOR LITTLE FALLS NJ 07424
Laura L Forese	director	849 STONEWALL COURT FRANKLIN LAKES NJ 07417
Peter Pronovost	director	JHU-QSRG 1909 THAMES ST. - 2ND FLOOR BALTIMORE MD 21231
Anthony B Evnin	director	C/O VENROCK ASSOCIATES, 7 BRYANT PARK, 23RD FLOOR, NEW YORK NY 10018
Ronnie Myers	director	TOURO COLLEGE OF DENTAL MEDICINE 40 SUNSHINE COTTAGE ROAD VALHALLA NY 10595
Alan R Batkin	director	399 PARK AVENUE, 10TH FLOOR, NEW YORK NY 10022
Karen Prange	director	1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316